BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B
BiohacksAI/Targets/RECEPTOR-INTERACTING/Compounds

Compounds That Target RECEPTOR-INTERACTING

Receptor-interacting serine/threonine-protein kinase 1 (human) · 3 compounds in BiohacksAI corpus

RECEPTOR-INTERACTING (Receptor-interacting serine/threonine-protein kinase 1 (human)) is a biological target with 3 documented compound interactions in the BiohacksAI corpus. The compounds listed below have been identified through computational analysis of BindingDB binding assay data and PubMed literature. Each interaction is ranked by confidence score reflecting the breadth and strength of experimental evidence. This resource supports research into RECEPTOR-INTERACTING modulation for therapeutic and biohacking applications.

View RECEPTOR-INTERACTING target page →UniProt: Q13546 ↗
Most Studied Compounds for RECEPTOR-INTERACTING
1
Sorafenib
300+
studies
2
Crizotinib
298+
studies
3
Axitinib
298+
studies
All 3 Compounds — Ranked by Evidence
1
Crizotinib
298+
studies
2.30
confidence
2
Sorafenib
300+
studies
1.10
confidence
3
Axitinib
298+
studies
0.69
confidence

The compounds above were identified through computational analysis of BindingDB binding assay data and PubMed literature for RECEPTOR-INTERACTING (Receptor-interacting serine/threonine-protein kinase 1 (human)). Confidence scores reflect the strength and breadth of experimental evidence.

Explore related resources: RECEPTOR-INTERACTING target overview · All biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.